Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
- Disease/Condition
- Systemic Lupus Erythematosus
- Drug/Device/Intervention
- CBC
- Study type
- Observational
- Intervention type
- diagnostic test
- Primary sponsor
- Sohag University
- Location
- Sohag, Egypt
- Phase
- N/A
- Start date
- Jan 10, 2024
- End date
- Aug 30, 2024
- Enrollment
- 100 participants
Evaluate the hematological indices as (mean platelet volume) of our SLE patient.,Evaluate the hematological indices as (neutrophil lymphocyte ratio) of our SLE patient.,Evaluate the hematological indices ( platelet lymphocyte ratio ) of our SLE patient.,Compare the degree of disease activity between the early-onset and late-onset patients with systemic lupus erythematosus.,Evaluate the correlation between hematological indices (mean platelet volume, platelet lymphocyte ratio and neutrophil lymphocyte ratio) and Systemic lupus erythematosus (SLE) disease manifestations and activity.
The present study aims to:
 
 Compare clinical features, hematological indices and disease activity between the early-onset
 and late-onset patients with systemic lupus erythematosus.
 
 Evaluate the relationship between hematological indices (mean platelet volume, platelet
 lymphocyte ratio and neutrophil lymphocyte ratio) and Systemic lupus erythematosus (SLE)
 disease manifestations and activity.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06294483
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06294483 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Enrolling by invitation. The study focuses on Systemic Lupus Erythematosus. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.